Why Is AVEANNA HEALTHCARE H (AVAH) Stock Moving Today?
AVEANNA HEALTHCARE H (AVAH) is drawing unusual attention today. Our newswire has captured 10 stories on AVAH across 6 sources in the last 36 hours, with AI sentiment reading bullish (avg 59/100).
Aveanna Healthcare Holdings (AVAH) shares rose 6.91% to $14.00 following the release of third-quarter financial results that exceeded consensus estimates. The primary driver of the move was a beat in non-GAAP earnings per share and a subsequent upward revision to full-year 2026 revenue and EBITDA guidance.
What Happened
The company reported third-quarter revenue of $695.5 million, representing an 11.8% increase over the prior year period. Net income for the quarter was $45.5 million, compared to $14.1 million in the same period last year. Non-GAAP EPS came in at $0.23, beating the consensus estimate of $0.21 by $0.02.
Aveanna Healthcare raised its full-year 2026 revenue guidance to more than $2.695 billion from a previous view of more than $2.68 billion. The company also lifted its adjusted EBITDA guidance to over $374 million from over $365 million. Raymond James reiterated a Strong Buy rating on the stock following the results. The company filed a Form 8-K with the SEC on November 12, 2026, disclosing the results of operations and financial condition.
What The Data Shows
The stock opened at $12.91, a 1.4% gap down from the prior close of $13.09. The session low was $12.26 at 7:25 AM ET, while the session high reached $14.19 at 9:35 AM ET. Volume so far stands at 0.3 million shares, which is 0.1 times the three-month daily average.
Fundamentals show a market cap of $2.9 billion and a P/E ratio of 10.6. Trailing twelve-month revenue growth is 19.5%, with a net margin of 10.6%. The stock has a beta of 2.01 and a 52-week range of $5.93 to $14.71. Over the last 8 sessions, the stock moved 0.2% from $13.12 to $13.09. Recent insider activity includes six sells totaling $558.5 million over the last 90 days, with no buys recorded. The most recent insider sale was filed on August 24, 2026.
What To Watch
Investors will monitor the stock's reaction to the revised 2026 guidance and any further analyst commentary following the earnings release.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
AVAH by the numbers
The headlines behind the move
Aveanna Healthcare: Q3 Beat And Higher Guidance Back Strong Buy Rating
Aveanna Healthcare offers an attractive investment opportunity after a post-earnings dip as exceptional forward growth drives a Strong Buy Quant Rating.
Aveanna Healthcare Highlights National Footprint in Investor Presentation
Aveanna Healthcare Holdings ( ($AVAH) ) has shared an announcement. On November 13, 2026, Aveanna made an investor presentation available to investors. The presenta...
Aveanna Healthcare Holdings, Inc. (AVAH) files 8-K: Items 7.01, 9.01
Filed: 2026-11-13 AccNo: 0001193125-26-459327 Size: 12 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Aveanna Healthcare: Revenue Growth, Guidance Raises, Yet Shares Still Trade At A Discount
Aveanna stock is rated a Buy at a 20% earnings discount; double-digit revenue growth and a 2027 California rate hike could support upside. See more on AVAH here.
Aveanna Healthcare (AVAH) Q3 2026 Earnings Call Transcript
Management reaffirmed growth targets and pushed AI-driven cost cuts.
Aveanna outlines 2026 revenue >$2.695B and adjusted EBITDA >$374M as preferred payer strategy expands
Aveanna Healthcare raises 2026 guidance to revenue above $2.695 billion and adjusted EBITDA above $374 million after Q3 revenue reaches $695.5 million.
Aveanna Healthcare Holdings Inc. (AVAH) Q3 2026 Earnings Call Transcript
Aveanna Healthcare Holdings Inc. (AVAH) Q3 2026 Earnings Call November 12, 2026 10:00 AM ESTCompany ParticipantsDebbie Stewart - Senior VP & Principal...
Aveanna Healthcare Just Keeps Raising The Bar
Aveanna Healthcare is rated a Buy and delivered another strong quarter, beating top- and bottom-line expectations. Read more on AVAH stock here.
Raymond James reiterates Strong Buy on Aveanna stock after beat
Raymond James reiterates Strong Buy on Aveanna stock after beat
Frequently asked questions
Why is AVAH stock moving today?
AVEANNA HEALTHCARE H (AVAH) is drawing unusual attention today. Our newswire has captured 10 stories on AVAH across 6 sources in the last 36 hours, with AI sentiment reading bullish (avg 59/100). The most recent driver: "Aveanna Healthcare Holdings Inc (AVAH) Stock Down 6.0% but Still Overvalued -- GF Score: 66/100" (GuruFocus).
Is AVAH a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of AVAH coverage reads 59/100 over 10 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More moves explained today
- Why is LFTO up today (+30.63%)
- Why is MOD up today (+27.86%)
- Why is HAWK up today (+23.79%)
- Why is HTFL down today (-19.13%)
- Why is VIR down today (-17.82%)
- Why is TNDM up today (+14.62%)
More on AVAH: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier AVAH move explainers: 2026-11-12 · 2026-08-24 · 2026-08-17